Everest Medicines Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-297.77	-1,041	-844.46	-247.28	-1,009
Depreciation & Amortization	153.57	128.62	72.75	40.23	30.76
Other Amortization	2.96	5	4.03	2.55	0.37
Loss (Gain) From Sale of Assets	0.03	-	1.43	-1,320	-
Asset Writedown & Restructuring Costs	333.23	356.34	51.97	16.49	-
Loss (Gain) From Sale of Investments	13.47	0.01	-0.85	21.75	-
Loss (Gain) on Equity Investments	39.15	-	-	-	-
Stock-Based Compensation	131.78	91.1	73.42	206.5	224.98
Provision & Write-off of Bad Debts	0.08	0.22	-	-	-
Other Operating Activities	-440.4	-48.35	-46.19	153.15	-11.67
Change in Accounts Receivable	-136.52	-313.93	-44.64	-5.17	-0.05
Change in Inventory	-18.19	2.86	-7.31	-11.19	-0.45
Change in Accounts Payable	291.09	106.69	-116.55	70.43	73.97
Change in Other Net Operating Assets	-165.03	33.32	87.22	-83.63	-39.13
Operating Cash Flow	-92.56	-679.51	-769.19	-1,156	-729.94
Capital Expenditures	-64.01	-65.41	-117.34	-355.92	-109.95
Sale of Property, Plant & Equipment	-	-	0.06	0.31	-
Sale (Purchase) of Intangibles	-284.33	-138.75	1,432	488.17	-865.87
Investment in Securities	-369.75	1,179	-568.77	-1,161	-
Other Investing Activities	35.72	-	6.57	-	-
Investing Cash Flow	-692.71	974.4	752.5	-1,028	-975.82
Long-Term Debt Issued	867.31	70	451.46	-	-
Total Debt Issued	867.31	70	451.46	-	-
Long-Term Debt Repaid	-520.96	-43.08	-463.2	-30.59	-23.66
Net Debt Issued (Repaid)	346.35	26.92	-11.74	-30.59	-23.66
Issuance of Common Stock	1,449	30.56	29.79	5.28	5.86
Repurchase of Common Stock	-	-	-	-	-58.71
Other Financing Activities	-22.42	-19.68	-7.95	-	-
Financing Cash Flow	1,773	37.8	10.1	-25.31	-76.51
Foreign Exchange Rate Adjustments	-27.51	28.72	38.87	59.83	-58.81
Net Cash Flow	959.92	361.41	32.28	-2,149	-1,841
Free Cash Flow	-156.57	-744.92	-886.53	-1,512	-839.89
Free Cash Flow Margin	-9.17%	-105.41%	-703.97%	-11817.36%	-1555344.44%
Free Cash Flow Per Share	-0.47	-2.32	-2.83	-5.08	-2.86
Cash Interest Paid	20.33	19.68	7.95	-	-
Levered Free Cash Flow	-228.39	-689.33	2,356	-2,031	-1,339
Unlevered Free Cash Flow	-213.84	-675.46	2,371	-2,028	-1,336
Change in Working Capital	-28.65	-171.07	-81.28	-29.56	34.35

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.